Mutual of America Capital Management LLC Sells 3,990 Shares of Danaher Co. (NYSE:DHR)

Mutual of America Capital Management LLC cut its stake in Danaher Co. (NYSE:DHR - Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 79,045 shares of the conglomerate's stock after selling 3,990 shares during the quarter. Mutual of America Capital Management LLC's holdings in Danaher were worth $21,976,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Danaher in the second quarter worth about $25,000. nVerses Capital LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $25,000. MFA Wealth Advisors LLC bought a new position in Danaher in the 2nd quarter valued at $51,000. Financial Connections Group Inc. purchased a new position in shares of Danaher during the 2nd quarter valued at $51,000. Finally, Western Pacific Wealth Management LP bought a new position in shares of Danaher in the first quarter worth $55,000. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 952 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Trading Down 3.7 %

Danaher stock traded down $8.88 during trading hours on Friday, reaching $230.50. The stock had a trading volume of 5,435,775 shares, compared to its average volume of 3,011,640. The company has a fifty day simple moving average of $262.20 and a 200-day simple moving average of $260.47. Danaher Co. has a 52 week low of $206.30 and a 52 week high of $281.70. The stock has a market cap of $166.49 billion, a PE ratio of 43.99, a PEG ratio of 4.24 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher's quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $2.02 earnings per share. Analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher's dividend payout ratio is presently 20.61%.

Wall Street Analyst Weigh In

DHR has been the subject of several research analyst reports. Bank of America lifted their price objective on Danaher from $270.00 to $275.00 and gave the company a "neutral" rating in a research note on Wednesday, July 24th. Stephens reissued an "overweight" rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research note on Wednesday, October 23rd. Barclays cut their price target on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 23rd. Finally, Raymond James lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.